SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs acquires equity shares in KRKA

17 Mar 2025 Evaluate

Laurus Labs has invested Rs 83.30 crore and acquired 83,300,000 equity shares of KRKA Pharma (KRKA) (a joint venture of the Company) a at face value of Rs 10 each by way of rights issue.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C.

Laurus Labs Share Price

1116.30 1.80 (0.16%)
22-Apr-2026 11:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.30
Dr. Reddys Lab 1218.90
Cipla 1230.95
Zydus Lifesciences 931.80
Lupin 2313.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×